| Timothy John Geraci, MD | |
|
975 Sereno Dr, 7th Floor, Vallejo, CA 94589-2441 | |
| (707) 651-2440 | |
| Not Available |
| Full Name | Timothy John Geraci |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 22 Years |
| Location | 975 Sereno Dr, Vallejo, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730202722 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | A87611 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kaiser Foundation Hospital - Zion | San diego, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southern California Permanente Medical Group | 6002729175 | 7951 |
News Archive
A new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Solove Research Institute (OSUCCC - James) has identified a protein within certain immune cells that is required for optimal immune responses to cancer.
Ligand Pharmaceuticals Incorporated today announced that data from a preclinical study on its selective androgen receptor modulator (SARM) LGD-4033 was featured in a poster presentation at the 62nd Annual Meeting of the Gerontology Society of America in Atlanta. LGD-4033 exhibited desirable in vivo efficacy on skeletal muscle and bone measurements in animal models of male hypogonadism and postmenopausal osteoporosis.
People with high cholesterol may have a higher risk of developing Alzheimer's disease, according to a study published in the September 13, 2011, issue of Neurology, the medical journal of the American Academy of Neurology.
Oncolytics Biotech Inc. has announced that it has started patient enrolment in a Phase 2 clinical trial using intravenous administration of Reolysin in combination with paclitaxel and carboplatin in patients with non-small cell lung cancer (NSCLC) with K-RAS or EGFR-activated tumours.
In a first, UK will get its voicebox or larynx transplant in less than a year after the Royal College of Surgeons gave its seal of approval for trials to take place. A report by the college said the pioneering procedure could help people who had cancer of the larynx to speak and breathe normally again.
› Verified 3 days ago
| Entity Name | Southern California Permanente Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770515280 PECOS PAC ID: 6002729175 Enrollment ID: O20031110000678 |
News Archive
A new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Solove Research Institute (OSUCCC - James) has identified a protein within certain immune cells that is required for optimal immune responses to cancer.
Ligand Pharmaceuticals Incorporated today announced that data from a preclinical study on its selective androgen receptor modulator (SARM) LGD-4033 was featured in a poster presentation at the 62nd Annual Meeting of the Gerontology Society of America in Atlanta. LGD-4033 exhibited desirable in vivo efficacy on skeletal muscle and bone measurements in animal models of male hypogonadism and postmenopausal osteoporosis.
People with high cholesterol may have a higher risk of developing Alzheimer's disease, according to a study published in the September 13, 2011, issue of Neurology, the medical journal of the American Academy of Neurology.
Oncolytics Biotech Inc. has announced that it has started patient enrolment in a Phase 2 clinical trial using intravenous administration of Reolysin in combination with paclitaxel and carboplatin in patients with non-small cell lung cancer (NSCLC) with K-RAS or EGFR-activated tumours.
In a first, UK will get its voicebox or larynx transplant in less than a year after the Royal College of Surgeons gave its seal of approval for trials to take place. A report by the college said the pioneering procedure could help people who had cancer of the larynx to speak and breathe normally again.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Timothy John Geraci, MD 7336 Rockway Ave, El Cerrito, CA 94530-3748 Ph: (510) 528-8520 | Timothy John Geraci, MD 975 Sereno Dr, 7th Floor, Vallejo, CA 94589-2441 Ph: (707) 651-2440 |
News Archive
A new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Solove Research Institute (OSUCCC - James) has identified a protein within certain immune cells that is required for optimal immune responses to cancer.
Ligand Pharmaceuticals Incorporated today announced that data from a preclinical study on its selective androgen receptor modulator (SARM) LGD-4033 was featured in a poster presentation at the 62nd Annual Meeting of the Gerontology Society of America in Atlanta. LGD-4033 exhibited desirable in vivo efficacy on skeletal muscle and bone measurements in animal models of male hypogonadism and postmenopausal osteoporosis.
People with high cholesterol may have a higher risk of developing Alzheimer's disease, according to a study published in the September 13, 2011, issue of Neurology, the medical journal of the American Academy of Neurology.
Oncolytics Biotech Inc. has announced that it has started patient enrolment in a Phase 2 clinical trial using intravenous administration of Reolysin in combination with paclitaxel and carboplatin in patients with non-small cell lung cancer (NSCLC) with K-RAS or EGFR-activated tumours.
In a first, UK will get its voicebox or larynx transplant in less than a year after the Royal College of Surgeons gave its seal of approval for trials to take place. A report by the college said the pioneering procedure could help people who had cancer of the larynx to speak and breathe normally again.
› Verified 3 days ago
Kenneston Carr, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 975 Sereno Dr, Vallejo, CA 94589 Phone: 707-651-1000 | |
Ine Maria George, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 975 Sereno Dr, Vallejo, CA 94589 Phone: 707-651-1000 | |
Michael S. Clark, MD Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 975 Sereno Dr, Vallejo, CA 94589 Phone: 707-651-1000 | |
Kimhai N. Lam, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 975 Sereno Dr, Vallejo, CA 94589 Phone: 707-651-1000 | |
Chase T. Lambrecht, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 975 Sereno Dr, Vallejo, CA 94589 Phone: 707-651-1000 | |
Scot P. Johnson, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 975 Sereno Dr, Vallejo, CA 94589 Phone: 707-651-1000 | |
Tom S. Cheng, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 975 Sereno Dr, Vallejo, CA 94589 Phone: 707-651-1000 |